ATL/Interspec regroups after merger
Ultrasound vendors ATL andInterspec have begun to reap benefits from their just-finalizedmerger. ATL's HDI CV cardiology ultrasound system was displayedat the Interspec booth at the American Society of Echocardiographyconference in San Francisco last
Ultrasound vendors ATL andInterspec have begun to reap benefits from their just-finalizedmerger. ATL's HDI CV cardiology ultrasound system was displayedat the Interspec booth at the American Society of Echocardiographyconference in San Francisco last month. The cardiology versionof Bothell, WA-based ATL's HDI platform was introduced in Europea year ago (SCAN 2/16/94).
HDI CV will now be handled by Interspec's cardiology-focusedsales force, allowing ATL's U.S. sales group to concentrate onradiology. In turn, Interspec's new Apogee RX400 radiology systemwill become a mid-tier offering in ATL's radiology line, positionedbeneath the premium Ultramark 9 HDI.
HDI CV was shown at the ASE meeting with two new probes. However,the enlarged ATL company has not yet combined Interspec technologywith its own. An Interspec-designed multifrequency pediatric transducerfor the HDI cardiac scanner should be coming soon.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
